Coronavirus Update: Japan Approves Lagevrio, Korea Clears Paxlovid
Plus, Boosters In Japan, Further Vaccine Progress In Korea
Executive Summary
Oral antivirals make progress in Asia as Japan issues emergency approval to Merck's Lagevrio in a matter of weeks and South Korea clears Pfizer's contender Paxlovid. Vaccines also move forward in both countries with deals for boosters, new supply agreements and the advancement of home-grown candidates.